|
Sign In to gain access to subscriptions and/or personal tools.
|
A Rapid Functional Assay for the Human Trace Amine-Associated Receptor 1 Based on the Mobilization of Internal Calcium
Hernán A. Navarro
Center for Organic and Medicinal Chemistry, RTI International, Research Triangle Park, North Carolina
Brian P. Gilmour
Center for Organic and Medicinal Chemistry, RTI International, Research Triangle Park, North Carolina
Anita H. Lewin
Center for Organic and Medicinal Chemistry, RTI International, Research Triangle Park, North Carolina
The molecular targets for trace amines (TAs) such as p-tyramine and ß-phenylethylamine have been recently discovered and have been shown to comprise a family of G-protein-coupled receptors based on DNA sequence homologies. These have been termed trace amine-associated receptors (TAARs) because TAs do not activate all of the identified receptors. Because TA may be involved in modulating a variety of behaviors including mood, cognition, and addiction, it is of interest to discover novel ligands for TAARs to probe the role TAs play in brain function. Pharmacophore development for the Gs-coupled human TAAR1 (hTAAR1) would be aided by a rapid functional assay amenable to screening libraries of compounds. Accordingly, the authors used RD-HGA16 CHO-1 cells from Molecular Devices, which stably express the promiscuous Gq, G 16, to create a cell line stably expressing hTAAR1, thereby coupling receptor activation to the mobilization of internal calcium. They used this cell line to develop a homogenous fluorometric imaging plate reader-based assay using the Calcium 3 fluorescent dye. The EC50 and Emax data obtained for known TAs are in close agreement with previous work using transient hTAAR1 expression systems or a chimeric receptor. These data indicate that the hTAAR1 retains its reported pharmacological characteristics when coupled to G 16.
Key Words: human trace amine calcium mobilization G 16
This version was published on September
1, 2006
Journal of Biomolecular Screening, Vol. 11, No. 6,
688-693 (2006)
DOI: 10.1177/1087057106289891

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. D. Sotnikova, M. G. Caron, and R. R. Gainetdinov
Trace Amine-Associated Receptors as Emerging Therapeutic Targets
Mol. Pharmacol.,
August 1, 2009;
76(2):
229 - 235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Maguire, W. A. E. Parker, S. M. Foord, T. I. Bonner, R. R. Neubig, and A. P. Davenport
International Union of Pharmacology. LXXII. Recommendations for Trace Amine Receptor Nomenclature
Pharmacol. Rev.,
March 1, 2009;
61(1):
1 - 8.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Xie, S. V. Westmoreland, M. E. Bahn, G.-L. Chen, H. Yang, E. J. Vallender, W.-D. Yao, B. K. Madras, and G. M. Miller
Rhesus Monkey Trace Amine-Associated Receptor 1 Signaling: Enhancement by Monoamine Transporters and Attenuation by the D2 Autoreceptor in Vitro
J. Pharmacol. Exp. Ther.,
April 1, 2007;
321(1):
116 - 127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Wainscott, S. P. Little, T. Yin, Y. Tu, V. P. Rocco, J. X. He, and D. L. Nelson
Pharmacologic Characterization of the Cloned Human Trace Amine-Associated Receptor1 (TAAR1) and Evidence for Species Differences with the Rat TAAR1
J. Pharmacol. Exp. Ther.,
January 1, 2007;
320(1):
475 - 485.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|